Moberg Pharma AB has rolled out Kerasal Nail Fungal Nail Repair, an extension of its Kerasal Nail product line. Moberg said CVS/pharmacy will be the first national drug chain to sell Kerasal Nail Fungal Nail Repair. Plans call for the product to launch in about 5,500 CVS drug stores in January.
Nozoil® Nasal Spray Product Availability Expands and Samples Offered to Consumers While product availability for Nozoil® Nasal Spray grows, consumers have the opportunity to try before they buy through the McKeon Products free sample giveaway program.
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New
Merck & Co. said Monday it will acquire Cubist Pharmaceuticals Inc. for $8.4 billion. The transaction will include $1.1 billion in net debt (based on projected cash balances) and other considerations for a total transaction value of about $9.5 billion.
GlaxoSmithKline PLC (GSK) has reversed a plan to possibly sell some of its established drugs in order to focus on fast-growing medications.
First Quality Tissue, a manufacturer of private-label and branded paper towels and tissue, is moving forward with several capacity expansion projects.
Galderma Laboratories’ Cetaphil skin care brand has made a foray in the baby product arena with the launch of Cetaphil Baby. Making its debut this week, the line includes five products: Cetaphil Baby Diaper Cream, Wash and Shampoo, Ultra Moisturizing Wash, Daily Lotion and Moisturizing Oil.
Avanir Pharmaceuticals Inc. has entered into an agreement to be acquired by Otsuka Pharmaceutical Co. Ltd. in a deal valued at $3.5 billion.
Actavis plc has released guanfacine hydrochloride tablets as part of a settlement agreement with Shire plc. Actavis said Monday that its product is a generic version of Shire’s Intuniv tablets, a medication for attention deficit hyperactivity disorder (ADHD).
Teva Pharmaceutical Industries Ltd. has launched amlodipine/valsartan/hydrochlorothiazide tablets, a hypertension medication, in the United States. Teva said Monday that its product is a generic equivalent of Exforge HCT tablets from Novartis.
PepsiCo make has made a pair of key executive appointments for its global operations. The food and beverage giant said Monday that Enderson Guimaraes, currently chief executive officer of PepsiCo Europe, has been named executive vice president of global categories and operations for PepsiCo.
Jelly Belly Candy Co. has introduced Draft Beer Jelly Bean Bottles in their own point-of-purchase display. Jelly Belly said Tuesday that the miniature plastic bottle is filled with 1.5 ounces of the Jelly Belly Draft Beer jelly beans, which made their debut this past spring.
Endo International plc has purchased the rights to Natesto testosterone nasal gel from Trimel BioPharma SRL, a subsidiary of Trimel Pharmaceuticals Corp.
David Heist, director of industry affairs and customer relations at Bayer Consumer Care, has announced his retirement. In an e-mail message to industry colleagues on Monday, Heist said he plans to retire from Bayer on May 1, 2015. He has served in his current position at Bayer for 20 years.
Perrigo Co. plc has launched an authorized generic version of Protopic Ointment 0.1% and 0.03%. Perrigo said Monday that it has begun shipping its generic product to pharmacies. Protopic Ointment (tacrolimus), from Astellas U.S. LLC, is indicated for the treatment of moderate to severe eczema.
